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Poloment, the sperm induces in the egg release of intracellular calcium ([Ca2+]i).
During oocyte maturation, the inositol 1,4,5-trisphosphate receptor (IP3R1), the channel implicated,
undergoes modiﬁcations that enhance its function. We found that IP3R1 becomes phosphorylated during
maturation at an MPM-2 epitope and that this persists until the fertilization-associated [Ca2+]i responses
cease. We also reported that maturation without ERK activity diminishes IP3R1 MPM-2 reactivity and [Ca2+]i
responses. Here, we show that IP3R1 is a novel target for Polo-like kinase1 (Plk1), a conserved M-phase
kinase, which phosphorylates it at an MPM-2 epitope. Plk1 and IP3R1 interact in an M-phase preferential
manner, and they exhibit close co-localization in the spindle/spindle poles area. This co-localization is
reduced in the absence of ERK activity, as the ERK pathway regulates spindle organization and IP3R1 cortical
re-distribution. We propose that IP3R1 phosphorylation by Plk1, and possibly by other M-phase kinases,
underlies the delivery of spatially and temporally regulated [Ca2+]i signals during meiosis/mitosis and
cytokinesis.
© 2008 Elsevier Inc. All rights reserved.Introduction
The activation of the egg is the ﬁrst stage in the initiation of embryo
development. It comprises a series of events that unfold soon after
interactionof the gametes and that endswith the completionofmeiosis
and progression into the mitotic cell cycles (Ducibella et al., 2002;
Schultz and Kopf, 1995). In all species studied to date, egg activation
requires a fertilization-associated increase in the intracellular concen-
tration of calcium ([Ca2+]i) (Stricker, 1999). In mammals, the fertilizing
[Ca2+]i signal consists of periodical rises, which are referred to as [Ca2+]i
oscillations (Miyazaki et al., 1993).
The type 1 inositol 1,4,5-trisphosphate receptor (IP3R1) in
mammals, or its homologue in other species, is responsible for the
majority of Ca2+ release during fertilization (Miyazaki et al., 1993).
IP3R1, the most widely expressed isoform (Taylor et al., 1999), is
distributed along the membrane of the endoplasmic reticulum (ER),
the main Ca2+ reservoir in the cell (reviewed in Berridge, 2002).
Production of inositol 1,4,5-trisphosphate (IP3), the IP3R1 ligand, is
detected during fertilization (Stith et al., 1993), and entails hydrolysisre).
n of this manuscript.
l rights reserved.of phosphatidylinositol (4,5)-bisphosphate by the action of a phos-
pholipase C (PLC; Rebecchi and Pentyala, 2000). During mammalian
fertilization, a sperm-speciﬁc PLC isoform, PLCζ (Saunders et al.,
2002), is reportedly responsible for IP3 production.
During oocyte maturation, the capacity of IP3R1s to mediate Ca2+
release and the oocytes' ability to mount [Ca2+]i oscillations are
enhanced (Terasaki et al., 2001; Jones et al., 1995a). For instance, prior
to maturation, at the germinal vesicle (GV) stage, oocytes display low
amplitude spontaneous [Ca2+]i rises (Jones et al., 1995a), and show
dampened responses to IP3 (Fujiwara et al., 1993). Nonetheless, IP3R1
sensitivity, which we deﬁne as the receptor's ability to conduct Ca2+ in
response to IP3, incrementally increases and becomes maximal by the
time of fertilization (Fujiwara et al., 1993), which in mammals and in
Xenopus eggs takes place at the metaphase of meiosis II (MII).
Therefore, in eggs, maximal IP3R1 sensitivity and maximal ability to
mount [Ca2+]i oscillations coexist. Fittingly, after fertilization and with
progression into interphase, both of these properties decline,
suggesting an association between IP3R1-mediated [Ca2+]i oscillations
and the M-phase stages of meiosis (Jellerette et al., 2004; Jones et al.,
1995b).
Several subcellular events that develop simultaneously during
maturation, such as an increased Ca2+ reservoir (Mehlmann and Kline,
1994; Tombes et al., 1992), a redistribution of the ER and IP3R1
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and an increase in IP3R1 concentration and sensitivity (Fissore et al.,
1999; Mehlmann et al., 1996) could explain the enhanced function of
IP3R1 in eggs. Furthermore, IP3R1 becomes phosphorylated during
maturation (Lee et al., 2006). Research shows that phosphorylation of
IP3R1 mostly enhances its Ca2+ release (reviewed in Patterson et al.,
2004), and that it can be phosphorylated by numerous kinases,
including protein kinase A and protein kinase C (Vermassen et al.,
2004; DeSouza et al., 2002), protein kinase G (Koga et al., 1994), Ca2+/
calmodulin-dependent protein kinase II (CaMKII) (Ferris et al., 1991),
the tyrosine kinases Fyn (Jayaraman et al., 1996) and Lyn (Yokoyama et
al., 2002), Rho kinase (Singleton and Bourguignon, 2002) and protein
kinase B (Khan et al., 2006). The aforementioned kinases do not
display association with the cell cycle and are therefore unlikely to
enhance IP3R1 function in MII eggs in a cell cycle-dependent manner.
Recent studies on IP3R1, however, have identiﬁed phosphorylation
consensus sites for Cyclin-Dependent Kinase 1 (Cdk1), also known as
Maturation Promoting Factor (MPF), and for Extracellular Signal-
Regulated Kinase (ERK), also known as Mitogen Activated Protein
Kinase (MAPK), both of which are pivotal regulators of oocyte
maturation (reviewed in Masui, 2001). In vivo and in vitro studies
have shown that Cdk1 (Malathi et al., 2003) and ERK (Lee et al., 2006;
Bai et al., 2006) phosphorylate several of these conserved motifs,
although their role in IP3R1 phosphorylation during fertilization
remains to be demonstrated.
In a previous study (Lee et al., 2006), we used theMPM-2 antibody,
which speciﬁcally recognizes M-phase phosphoproteins with phos-
phorylated serine (Ser)/threonine (Thr) next to proline (Pro) (Wes-
tendorf et al., 1994; Davis et al., 1983), the basic phosphorylationmotif
of Cdk and ERK kinases, to examine the possible involvement of M-
phase kinases on IP3R1 phosphorylation in oocytes/eggs. We found
that IP3R1 ﬁrst becomesMPM-2 phosphorylated at the time ofmeiosis
resumption, the germinal vesicle breakdown stage (GVBD), and
remains phosphorylated at the MII stage. Following fertilization,
MPM-2 IP3R1 phosphorylation decreases in a protracted manner, later
than the decline in Cdk1 activity but in parallel with the decline in ERK
activity. Consistent with this, inhibition of the ERK pathway during
maturation reduced MPM-2 IP3R1 phosphorylation in MII eggs as well
as IP3R1-mediated [Ca2+]i oscillations (Lee et al., 2006). Although these
results suggested a role for the ERK pathway in IP3R1 MPM-2
phosphorylation in eggs, whether ERK is required for the initial
phosphorylation and whether it directly phosphorylates the IP3R1
MPM-2 epitope was not elucidated.
Another MPM-2-epitope generating kinase that is activated at the
time of meiosis resumption (reviewed in Liu and Maller, 2005b) is
Polo-like kinase 1 (Plk1) (do Carmo Avides et al., 2001; Kumagai and
Dunphy, 1996). Polo function was ﬁrst identiﬁed in Drosophila
melanogaster larvae that showed cellular abnormalities in the
organization of the spindle and spindle poles (Sunkel and Glover,
1988). Since then, research shows that Plk1 and its orthologs are
serine/threonine kinases that play crucial roles in almost every phase
of mitosis and cytokinesis (Lowery et al., 2007; reviewed in Barr et al.,
2004). Of relevance to our studies is that Plk1 becomes activated at the
onset of oocyte maturation, the GVBD stage, and remains active
throughout maturation (Okano-Uchida et al., 2003; Pahlavan et al.,
2000; Qian et al., 1998). Moreover, after fertilization, Plk1 becomes de-
phosphorylated/inactivated well after extrusion of the second polar
body (Pahlavan et al., 2000), whichmirrors the proﬁle of IP3R1MPM-2
reactivity during maturation and after fertilization (Lee et al., 2006).
Collectively, these ﬁndings raise the prospect that Plk1 may be
involved in MPM-2 IP3R1 phosphorylation in eggs. In this study,
therefore, our goal was to unravel those kinases commonly associated
with oocyte maturation that are responsible for IP3R1 MPM-2
phosphorylation, and elucidate the mechanism by which the ERK
pathway regulates this phosphorylation. Our results show that IP3R1
is a novel and hitherto unknown substrate of Plk1, and that the IP3R1MPM-2 epitope phosphorylation by Plk1 in MII eggs is regulated by
the ERK pathway, which controls IP3R1 redistribution and affects Plk1
spindle localization during oocyte maturation.
Materials and methods
Collection of oocytes/eggs and culture conditions
GV and MII eggs were collected from the ovaries and oviducts of 5 to 8 weeks-old
CD-1 female mice, respectively, as previously described (Lee et al., 2006). GV oocytes
were recovered in HEPES-buffered Tyrode-Lactate solution (TL-HEPES) supplemented
with 5 % heat-treated fetal calf serum (FCS; Gibco, Grand Island, NY) and 100 μM 3-
isobutyl-1-methylxanthine (IBMX; Sigma, St. Louis, MO; all chemicals from Sigma
unless otherwise speciﬁed). Oocytes were matured in vitro for 12–16 h in a humidiﬁed
atmosphere containing 6% CO2 in Chatot, Ziomek, and Bavister (CZB) medium (Chatot et
al., 1990) containing 3mg/ml polyvinyl alcohol (PVA) at 36.5°C. MII eggs were recovered
in TL-HEPES and, after removal of cumulus cells, eggs were transferred into 50 μl drops
of KSOM (Potassium Simplex OptimizedMedium; SpecialtyMedia, Phillipsburg, NJ) and
cultured as above. Animal handling and procedures were approved by the University's
IACUC committee.
Microinjection procedures and preparation of Plk1 mRNA
Oocytes and eggs were microinjected as previously described (Lee et al., 2006).
Reagents were diluted in injection buffer (100 mM KCl and 10 mM HEPES, pH 7.0),
loaded into glass micropipettes by aspiration and delivered into the ooplasm by
pneumatic pressure (PLI-100 picoinjector, Harvard Apparatus, Cambridge, MA); each
egg received 3–10 pl (1–3% of the total volume of the egg). Mouse Plk1 cDNA (Accession
No. 18817) from mouse testis was ampliﬁed by PCR using previously reported primers
(Clay et al., 1993) and cloned into the pCS2+ vector (Turner and Weintraub, 1994). A
constitutively active (CA) form of the kinase was generated by substituting threonine
(T) 210 by aspartate (D) (Jang et al., 2002) using the QuickChange mutagenesis kit
(Stratagene, La Jolla, CA); a construct encoding only the polo box domain of Plk1 was
produced as described by the same authors and cloned into pCS2+. The sequence
encoding for Venus (a gift from Dr. Miyawaki, Riken, Japan to Dr. J. Ito), a yellow
ﬂuorescent protein variant (Nagai et al., 2002), was also subcloned into pCS2+. cDNAs
were in vitro transcribed using the mMESSAGE mMACHINE capping kit (Ambion,
Austin, TX) and generated mRNAs handled as previously reported (Lee et al., 2006).
Antibodies
Two polyclonal antibodies raised against the same peptide sequence on the C-
terminal end of the molecule were used to detect IP3R1. Rbt03 (Parys et al., 1995) was
used for western blotting (WB) whereas CT1 (Wojcikiewicz et al., 1994), which was
afﬁnity puriﬁed, was used for immunolocalization studies. The MPM-2 monoclonal
antibody (Upstate, Lake Placid, NY) was used to ascertain IP3R1 phosphorylation as
previously reported (Jellerette et al., 2004). Detection of total and phosphorylated forms
of Plk1 was accomplished using a cocktail of mouse monoclonal antibodies against
mPlk1 (Zymed, San Francisco, CA) and an anti-phospho (T210) Plk1 polyclonal antibody
(Rockland Immunochemicals, Gilbertsville, PA), respectively.
Immunoblotting
Forty to 50 mouse oocytes/eggs or cell lysates from 0.5 to 6.0 Xenopus eggs were
mixed with 2× Laemmli sample buffer (2× SB) (Laemmli, 1970), boiled and loaded onto
NuPAGE Novex 3–8% Tris-Acetate gels (Invitrogen, Carlsbad, CA), or onto 7.5% gels made
with 120:1 acrylamide:bisacrylamide mixture (Hamanaka et al., 1995). After electro-
phoresis, proteins were transferred onto nitrocellulose membranes (Micron Separa-
tions, Westboro, MA) and successive probing of both MPM-2/IP3R1 and phospho-Plk1/
Plk1 was performed as described by our laboratory (Lee et al., 2006). Species-speciﬁc
horseradish peroxidase-labeled secondary antibodies and chemiluminescence (NEN
Life Science Products, Boston, MA) were used according to the manufacturer's
instructions. Each nitrocellulose membrane was digitally captured and quantiﬁed
using an imaging system (Kodak Imaging Station 440 CF, Rochester, NY); quantiﬁcation
was performed on the TIFF ﬁles before any rendering was carried out and was
performed only between lanes from the same blot membrane. The relative intensities of
MPM-2 and phospho-Plk1 immunoreactive bands and of phosphorylated substrate
bands in kinase assays were plotted using Sigma Plot (Jandel Scientiﬁc Software, San
Rafael, CA) using MII eggs as the normalizing value. Figures were prepared using ImageJ
software (NIH; http://rsb.info.nih.gov/ij/) and Microsoft PowerPoint. To improve the
order of presentation, some lanes within the same membrane were cut and pasted and
two short parallel lines denote this action.
Immunoﬂuorescence
Oocytes/eggs were prepared for immunoﬂuorescence (IF) by removing the zona
pellucida (acid Tyrode solution, pH 2.7) followed by washes in 0.1% BSA-supplemented
Dulbecco's PBS (DPBS-BSA). Cells were ﬁxed in 3.7% paraformaldehyde+0.02% Triton
X-100, permeabilized with 0.1% Triton X-100 DPBS-BSA, and blocked in 5% normal
goat serum-DPBS. Primary antibodies, mPlk1 antibodies and the CT1 antibody were
Fig. 1.MPM-2 phosphorylation of IP3R1 is regulated independently of the ERK pathway
during the early stages of maturation. (A) Immunoblotting of oocyte lysates collected at
GV (0 h), MI (8 h) and MI (8 h) after treatment with U0126 or U0124 for the indicated
times and probed with the MPM-2 antibody (upper panel) and, after stripping of the
blot, with the IP3R1 antibody Rbt03 (lower panel). Quantiﬁcation of IP3R1 MPM-2
reactivity is shown in the graph below the immunoblotting panels. Data are presented
as means±S.E.M., and bars with different superscripts are signiﬁcantly different
(Pb0.05) both here and elsewhere. The pair of short parallel lines indicates a lane that
was moved from within the same blot. (B) Immunoblotting of lysates of GV, MII (12 h)
eggs in the presence of colcemid and treated with U0126 or U0124 and (C) of oocytes
cultured for 0 (GV), 1, 2 (BD), 3 and 4 h probed as described above. For panel B, similar
results were observed without colcemid.
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mouse IgG and Alexa ﬂuor 555 goat anti-rabbit IgG (Molecular Probes, Eugene, OR),
respectively, and were incubated for 1 h at room temperature (RT). Fixed specimens
were mounted with Vectashield Mounting Medium (Vector Laboratories, Burlingame,
CA). Slides were examined at RT with a confocal laser-scanning microscope (510
META, Carl Zeiss Microimaging, Inc., Germany) using an Axiovert 2 microscope
outﬁtted with a 63×1.4 NA oil immersion objective lens. Z-stack images were collected
from cortical to equatorial planes every 2 to 5 μm and exported as TIFF ﬁles using Zeiss
software, and TIFF ﬁles were processed using Photoshop (Adobe) and assembled in
PowerPoint (Microsoft). Negative control eggs were incubated without the primary
antibody but with both secondary antibodies, or with the primary antibody (CT1) pre-
treated with the antigenic peptide (10 μg/ml).
Preparation of pharmacological inhibitors
Wortmannin (WTMN), a commonly used PI 3-kinase inhibitor, was used to inhibit
Plk1 (Liu et al., 2005; Liu et al., 2007). Wortmannin was dissolved in DMSO and further
diluted in CZB-PVA. Wortmannin-supplemented medium was replaced every 4 h
(Kimura et al., 1994). U0126 (Calbiochem, San Diego, CA), a MEK-speciﬁc inhibitor, was
prepared in DMSO and used at 25 μM; the inactive analog U0124 was used as a negative
control. Doxorubicin (DXR) was diluted in H2O and used at 1 μM in CZB-PVA (Jurisicova
et al., 2006).
Histone 1 (H1) and myelin basic protein (MBP) kinase assays and kinase inhibitors
The activities of Cdk1 and ERK were assayed using lysates from 5 oocytes as
described previously (Lee et al., 2006). Proteins were separated on 15% SDS-
polyacrylamide gels, and H1 and MBP phosphorylations visualized by autoradiography.
Autoradiographs were scanned and quantiﬁed as described for WB.
Preparation of Xenopus eggs/zygotes lysates and immunoprecipitation
Xenopus eggs were collected from mature females and after in vitro fertilization, as
per standard protocols. For IP experiments, groups of 25 eggs were frozen on dry ice and
solubilized with 500 μl cold embryo solubilization buffer containing 1.0% Triton X-100
(Cousin et al., 2000). After pelleting cellular debris, supernatants were incubated
overnight at 4°C with non-immune serum, Rbt03 antibody, MPM-2 antibody or Plk1
antibody with head-over-head rotation. Incubation of protein A sepharose beads
(Amersham) with immunocomplexes occurred for an additional 3 h before several
washes with PBS. Samples were denatured by addition of 2× SB and stored at -80°C
until WB was performed.
Statistical analysis
Values from three or more experiments performed on different batches of oocytes,
eggs or zygotes were used for evaluation of statistical signiﬁcance. Statistical
comparisons of band intensities after WB and kinase assays were performed using
the Student's t-test or one-way ANOVA and, if differences were found between groups,
they were resolved using the Tukey/Kramer test using the JMP-IN software (SAS
Institute, Cary, NC). Differences were considered to be signiﬁcant when Pb0.05.
Signiﬁcance among groups/treatments is denoted in bar graphs by different super-
scripts (WB) or by the presence of one or two asterisks (kinase assays).
Results
The ERK pathway is not required for the initial IP3R1 MPM-2 epitope(s)
phosphorylation during oocyte maturation
In a previous study, we found that the IP3R1 MPM-2 phosphoryla-
tion during oocyte maturation was greatly diminished when oocytes
were matured to the MII stage in the presence of the MEK inhibitor
U0126 (Lee et al., 2006); these results implicate the ERK pathway in
IP3R1 phosphorylation at the MPM-2 epitope(s). To determine
whether the ERK pathway is required for IP3R1 MPM-2 phosphoryla-
tion at earlier stages, we cultured oocytes in the presence or absence
of U0126 and collected samples for WB 8 h after the initiation of
maturation, the time at which oocytes had reached the metaphase
stage of meiosis I (MI). Oocytes at the GV stage were devoid of IP3R1
MPM-2 reactivity and, as they matured, they became phosphorylated
regardless of the presence of U0126 (Fig. 1A, upper panel), suggesting
that the ERK pathway is not required for the initial MPM-2 IP3R1
phosphorylation; probing for IP3R1 after stripping of the membranes
showed that receptor concentrations during this period remained
stable (Fig. 1A., lower panel). Besides conﬁrming that U0126
prevented ERK activity in these oocytes (data not shown), oocyteswere also matured to the MII stage in the presence of U0126,
replicating our previous experiments (Lee et al., 2006). Not unexpect-
edly, this procedure greatly decreased IP3R1 MPM-2 reactivity in MII
eggs (Fig. 1B, upper panel) without affecting IP3R1 concentrations
(Fig. 1B, lower panel); this last experiment was performed in the
presence of colcemid to avoid the exit of metaphase stage that is
known to occur in oocytes in which the ERK pathway is suppressed
during maturation (Araki et al., 1996). Together, these results show
that the ERK pathway is required to maintain IP3R1 MPM-2
phosphorylation during theMI toMII transition, but it is not necessary
Fig. 2. IP3R1 MPM-2 reactivity and Plk1 phosphorylation correspond during oocyte maturation and the early zygotic stage. (A) Immunoblotting of oocyte lysates collected at 0 (GV), 1,
2 (BD), 3 and 4 h probed with a phospho-Plk1 (p-Plk1) antibody (upper panel) and, after stripping, re-probed with a Plk1 antibody (lower panel). (B) Immunoblotting of lysates of GV
(0 h), MI (8 h), MII (12 h) oocytes and PN (18 h) zygotes probed with a Plk1 antibody. In panels A and B, proteins were separated on 7.5% gels made with 120:1 acrylamide:
bisacrylamide mixture, and the upper arm of the bracket at the right side of the blot points to the phosphorylated Plk1 variant. (C) Immunoblotting of lysates of GV, BD, MI and MII
oocytes and (D) of MII (12 h), 2PB (14 h), PN (18 h) and MitI (29 h) eggs/zygotes shows MPM-2 reactivity (upper panel) and p-Plk1 reactivity (3rd panel). After stripping, IP3R1
reactivity (Rbt03; 2nd panel) and Plk1 reactivity (lower panel) were demonstrated. p-Plk1 intensity is shown in the graph below the immunoblotting panels.
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MPM-2 epitope(s).
To gain insight into the kinase responsible for IP3R1 MPM-2
phosphorylation, we investigated when this phosphorylation ﬁrst
occurred during oocyte maturation. The ﬁrst noticeable IP3R1 MPM-2
immunoreactivity occurred 1 h after initiation of maturation,
continued to increase until the 2nd h, the time at which all oocytes
had undergone GVBD, and reached maximal levels by 3 h (Fig. 1C,
upper panel), all this time ERK activity remains basal (Verlhac et al.,
1994) and the levels of IP3R1 remained unchanged (Fig. 1C, lower
panel). The results therefore show that IP3R1 MPM-2 phosphorylation
is set early in oocyte maturation prior to ERK activation.
IP3R1 MPM-2 phosphorylation during oocyte maturation coincides with
activation of Plk1
The early appearance of IP3R1 MPM-2 reactivity in oocytes leads
to the expectation that the responsible kinase(s) must play a role
early in oocyte maturation. Plk1 has been implicated in the G2-M
transition in oocytes by virtue of phosphorylating and activating
Cdc25C (Qian et al., 1998; Kumagai and Dunphy, 1996), the
phosphatase responsible for Cdk1 activation, which in turn
orchestrates the initiation of oocyte maturation (Nebreda and
Ferby, 2000). Furthermore, Plk1, or its Xenopus homologue Plx1,
has been shown to generate MPM-2 reactive epitopes on target
proteins (do Carmo Avides et al., 2001; Kumagai and Dunphy, 1996).
To ascertain Plk1 activity in oocytes and zygotes, we evaluated two
properties of Plk1 that correspond with its activation. First, becausePlk1 activation coincides with its phosphorylation (Mundt et al.,
1997), which in turn retards its migration during SDS-polyacryla-
mide gel electrophoresis (Hamanaka et al., 1995), we examined
whether or not Plk1 undergoes mobility shifts during oocyte
maturation and after egg activation. Second, speciﬁc phosphoryla-
tion on Thr210 of Plk1 in mammals, or the equivalent Thr201 residue
of Plx1 in Xenopus, is indispensable for activation and in vitro kinase
activity of Plk1 (Jang et al., 2002; Qian et al., 1999); we therefore
analyzed phosphorylation at this residue using an anti-phospho
(Thr210) Plk1 antibody. By either method, Plk1 appeared depho-
sphorylated and therefore inactive at the GV stage, but showed initial
signs of phosphorylation by 1 h of maturation and became progres-
sively more phosphorylated for the next 3 h of culture (Fig. 2A).
Thereafter, Plk1 remained phosphorylated until the MII stage (Fig. 2B,
left and center panels), although it underwent dephosphorylation after
exposure to SrCl2, which induced egg activation and PN formation (Fig.
2B, right panel). Our results therefore show that the proﬁles of Plk1
activity and IP3R1 MPM-2 reactivity in oocytes and zygotes closely
correspond.
To more precisely determine whether IP3R1 MPM-2 epitope
phosphorylation and Plk1 phosphorylation/activity temporally over-
lap, we simultaneously examined IP3R1 MPM-2 reactivity and Thr210
Plk1 phosphorylation in the same groups of oocytes, eggs and zygotes.
GV stage oocytes were devoid of both MPM-2 reactivity and
phosphorylated Plk1 although, by the time of GVBD and through the
MI and MII stages, high IP3R1 MPM-2 reactivity was accompanied by
increased levels of phospho-Plk1 reactivity (Fig. 2C); neither protein
showed alteration in total concentrations (Fig. 2C). Following egg
Fig. 3. Completion of GVBD and IP3R1 MPM-2 reactivity occurs in the absence of Cdk1 activity. OA activates ERK and Plk1 in the presence of IBMX. (A) Percentage (%) of oocytes
(control, 1 h OA pulse+ IBMX, and IBMX) that underwent GVBD at different times of in vitromaturation; at least 30 oocytes were examined per treatment and time point. (B) Kinase
assays. H1 and MBP phosphorylation indicates Cdk1 and ERK activities, respectively. Oocytes were cultured for 0, 2, 5, 8 h±IBMX and ±1h OA pulse. Quantiﬁcation of kinase activities
is shown below the autoradiograph. BD under the 2 h time point stands for GVBD. (C) Immunoblotting of oocyte lysates collected at 0 h (GV), 8 h (MI) treated with IBMX+1 h OA pulse,
8 h (GV) with IBMX and 8 h control (MI) and probed with MPM-2 antibody (left panel) and p-Plk1 antibody (right panel) and after stripping re-probed with IP3R1 (Rbt03) and Plk1
antibodies, respectively. Quantiﬁcation of IP3R1 MPM-2 reactivity and p-Plk1 intensity is shown in the graph below the immunoblotting panels.
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until the time of PN formation (Fig. 2D), although, while MPM-2 IP3R1
reactivity remained low at mitosis I, phospho-Plk1 reactivity
rebounded (Fig. 2D). Collectively, these results show that throughout
meiosis and the early zygote stage, IP3R1 MPM-2 reactivity corres-
ponds with Plk1 phosphorylation/activity suggesting a role for Plk1 in
IP3R1 MPM-2 phosphorylation.
IP3R1 MPM-2 phosphorylation occurs in oocytes matured in the absence
of CDK1 activity
Cdk1/MPF activity also operates early during oocyte maturation
(reviewed in Masui, 2001). Thus, to discern the possible impact of this
kinase on IP3R1 MPM-2 reactivity, we induced oocyte maturation
while precluding Cdk1/MPF activity. Accordingly, oocytes were
incubated with IBMX, a phosphodiesterase inhibitor that maintains
the GV arrest, and treated for 1 h with okadaic acid (OA), a
phosphatase inhibitor; it is known that under these conditions
oocytes undergo GVBD in the presence of negligible levels of Cdk1
activity (Phillips et al., 2002; de Vantery Arrighi et al., 2000). Our
results indeed show that IBMX-imposed GV arrest can be relieved by
OA treatment (Fig. 3A), and that resumption of meiosis is accom-
plished in the absence of Cdk1 activity as evidenced by the lack of H1
phosphorylation (Fig. 3B). Even under these conditions, IP3R1s
showed near normal levels of MPM-2 reactivity (Fig. 3C, left panel),suggesting that a kinase other than Cdk1 is responsible for this
phosphorylation. While ERK undergoes robust and premature activa-
tion in IBMX-OA-treated oocytes (Fig. 3B), given our previous results,
it is unlikely that it would be responsible for the IP3R1 MPM-2
reactivity. Moreover, treatment of somatic cells with OA has been
shown to lead to Plk1 activation in an ERK pathway-dependent
manner (Liu et al., 2004a). Consistent with this observation, IBMX-OA-
treated oocytes showed maximal Plk1 activation (Fig. 3C, right panel).
Together, our results show that Cdk1 is not responsible for the IP3R1
MPM-2 phosphorylation in oocytes and that, instead, Plk1 activity (as
indicated by the p-Plk1 levels) seems more intimately associated with
this phosphorylation.
Pharmacological inhibition of Plk1 activation precludes IP3R1 MPM-2
phosphorylation
Two pharmacological inhibitors were used to ascertain whether
IP3R1 MPM-2 phosphorylation requires active Plk1. The ﬁrst inhibitor
tested was wortmannin, a well-known and broadly used phospha-
tidylinositol 3-kinase (PI3K) inhibitor (Cross et al., 1995). Research
shows that at the concentrations routinely used to block PI3K in
somatic cells, wortmannin also efﬁciently inhibits Plk1 activity (Liu
et al., 2005). We therefore examined whether wortmannin was
effective at blocking Plk1 activity in oocytes. First, a concentration-
dependent study was performed to investigate the effects of
Fig. 4. Inhibition of Plk1 activity by Wortmannin (WTMN) or Doxorubicin (DXR) abolishes IP3R1 MPM-2 reactivity and delays progression to GVBD and MII. Percentage of oocytes
(control, 0.1, 1 or 10 μM WTMN) that underwent progression to GVBD (A) and MII (B) during maturation; at least 30 oocytes were examined per concentration and time point.
Immunoblotting of oocyte lysates collected at 0, 2, 8 and 12 h±1 μMWTMN (C) or ±1 μM DXR (D) probed with MPM-2 (upper panel) antibody and p-Plk1 antibody (3rd panel) and,
after stripping, re-probed with IP3R1 antibody (Rbt03; 2nd panel) and Plk1 (lower panel), respectively. Relative p-Plk1 intensity is shown for both (C and D) in the graphs below the
immunoblotting panels.
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of GVBD (Fig. 4A) and progression to the MII stage in a concentra-
tion-dependent manner (Fig. 4B), although 0.1 and 1 μM wortman-
nin did not affect the total number of oocytes completing maturation
(Fig. 4B); 10 μM wortmannin affected both progression to GVBD and
MII and, therefore, it was not used further (Figs. 4A, B). Consistent
with the effect on meiotic progression, in vitro kinase assays
revealed that 1 μM wortmannin delayed activation of Cdk1 and
ERK, although both kinase activities fully recovered by the time
oocytes had reached the MII stage (data not shown). Remarkably,
under similar conditions, wortmannin prevented phosphorylation
and activation of Plk1, and the acquisition of MPM-2 reactivity by
IP3R1 (Fig. 4C). As the PI3K/PKB pathway plays a role in meiotic
progression (Hoshino et al., 2004), the latter effects of wortmannin
could in theory be attributed to its inhibition of PI3K activity.
Nevertheless, this is unlikely given that during oocyte maturation
PKB activation is transient (Kalous et al., 2006), and that its
phosphorylation consensus motif (Lawlor and Alessi, 2001) differs
greatly from the MPM-2 epitope.
The second inhibitor used was the anti-tumor antibiotic doxor-
ubicin, which induces DNA damage and triggers the DNA-damage
checkpoint in somatic cells, reportedly inactivating and dephosphor-
ylating Plk1 (Jang et al., 2007). We therefore examined the effect of
1 μM doxorubicin on maturation-associated IP3R1 MPM-2 phosphor-
ylation. Although doxorubicin-treated oocytes resumed and pro-
gressed through meiosis, doxorubicin inhibited IP3R1 MPM-2
phosphorylation as well as the occurrence of phospho-Plk1 at all of
the time points examined (Fig. 4D). Together, the data provide
evidence that active Plk1 is required for IP3R1 MPM-2 phosphoryla-
tion during oocyte maturation.Molecular manipulations of Plk1 inﬂuence IP3R1 MPM-2
phosphorylation
Plk1, like other family members, consist of a canonical Ser/Thr
kinase domain at the N terminus and two signature motifs, the polo
boxes, at the C terminus, which form the polo box domain (PBD)
(reviewed in Barr et al., 2004; Kumagai and Dunphy, 1996) (Fig. 5A).
The PBD has been implicated in the regulation of the catalytic activity
of the enzyme as well as in the targeting of Plks to speciﬁc cellular
structures (Lee et al., 1998). Recent research showed that the PBD acts
as a phosphopeptide-binding motif (Elia et al., 2003a) recognizing
“primed phosphoepitopes” on Plk1 target proteins. It stands to reason
that disruption of PBD function should interfere with the progression/
completion of Plk1-controlled cellular events. Consistent with this
notion, overexpression of a kinase dead Plx1 protein delayed the
activation of Cdc25C and initiation of GVBD in Xenopus oocytes (Liu et
al., 2004b). Accordingly, we overexpressed in mouse oocytes a PBD-
Plk1 mRNA to compete with endogenous Plk1 (PBD-Plk1; Fig. 5A). We
found that while injection of PBD-Plk1 mRNA markedly delays GVBD,
it does not affect the percent of oocytes that are able to complete this
process (Fig. 5B). More speciﬁcally, we observed that while ∼40% of
buffer control injected oocytes or of the oocytes injected with mRNA
encoding for the Venus ﬂuorescent protein had undergone GVBD by
1.5 h of maturation and nearly all oocytes had undergone GVBD by 2.5
h, only 5% and 50%, respectively, of PBD-Plk1 mRNA injected oocytes
had completed GVBD at those times of maturation (Fig. 5B). Injection
of PBD-Plk1 mRNA also greatly prevents IP3R1 MPM-2 phosphoryla-
tion by 2 h of maturation (Fig. 5C, left panel), although it did not affect
the levels of phospho-Plk1 (Fig. 5C, right panel) or the total amounts of
IP3R1 and Plk1 proteins (Fig. 5C, lower panels).
Fig. 5. Overexpression of PBD-Plk1 delays GVBD and inhibits IP3R1 MPM-2 reactivity. (A) Schematic overview of the different Plk1 constructs. Wild type Plk1 (WT-Plk1) consists of a
kinase domain and two Polo Boxes. PBD-Plk1 encodes only for the 2 Polo Boxes, and the CA Plk1 has residue Thr210 substituted by Asp (CA(T210D)-Plk1). (B) Percentage of oocytes
injectedwith buffer, venusmRNA (control) or with PBD-Plk1 mRNA that underwent GVBD after initiation of maturation; at least 20 oocytes were examined per group and time point.
(C) Immunoblotting of oocyte lysates obtained after injectionwith PBD-Plk1 mRNA or buffer and collected at GVBD (2 h) or from buffer-injected GV andMII oocytes. Immunoblottings
were probed with MPM-2 (left panel) or p-Plk1 antibody (right panel) and after stripping with IP3R1 (Rbt03) or Plk1 antibody, respectively. Quantiﬁcation of MPM-2 or p-Plk1
intensity is shown in the graph below the immunoblotting panels.
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overexpressed the constitutively active (CA) form of Plk1, CA(T210D)-
Plk1 (Fig. 5A) (Jang et al., 2002). Previously, injection of a similar
construct into Xenopus oocytes induced premature activation of
Cdc25C and GVBD (Qian et al., 1999). Similarly, injection of the CA
(T210D)-Plk1 mRNA into mouse oocytes evoked premature GVBD
(Fig. 6A). We next examined whether CA(T210D)-Plk1 mRNA injection
induced IP3R1 MPM-2 epitope phosphorylation. To circumvent the
confounding effect of phosphorylation by endogenous kinases, all
oocytes were kept in IBMX-supplemented media such that GVBD and
activation of Cdk1 and ERK activities were precluded (de Vantery
Arrighi et al., 2000). In the presence of IBMX, all groups remained at
the GV stage (Fig. 6B). Nonetheless, despite the arrest at the GV stage,
CA(T210D)-Plk1-injected oocytes showed signiﬁcant IP3R1 MPM-2
reactivity, which was not the case for buffer injected oocytes (Fig. 6B,
left panel). Injection of CA(T210D)-Plk1 mRNA did not alter the
expression of IP3R1 or phospho-Plk1, although it increased the total
amount of Plk1, demonstrating that the CA(T210D)-Plk1 mRNA
underwent in vivo translation in the oocyte (Fig. 6B, right panel).
Collectively, these data suggest that manipulation of Plk1 activity
inﬂuences IP3R1 MPM-2 phosphorylation, directly implicating this
kinase in IP3R1 phosphorylation.
IP3R1 and Plx1 interact in a cell cycle-stage preferential manner in
Xenopus eggs/zygotes
We next performed immunoprecipitation (IP) studies to investi-
gate whether Plk1 and IP3R1 interact. For these studies, we choseXenopus egg extracts because of the large availability of material in
this species, and because in Xenopus eggs Plx1 also becomes depho-
sphorylated/inactivated after fertilization and transition into inter-
phase (Descombes and Nigg, 1998) (Fig. 7A). IP of Xenopus MII egg
extracts using an anti-IP3R1 antibody brought down Plx1 (Fig. 7B, left
part), demonstrating direct association of these two molecules; IP of
the same extracts using non-immune serum (far left lane) or with
beads alone (far right lane) failed to do so. We next examinedwhether
this interaction occurred in a cell cycle-preferential manner. We found
that association of IP3R1 and Plx1 was higher at the MII stage than at
the interphase stage (Fig. 7B, bar graphs), which is similar to the
preferential association between Plk1 and other substrates during
M-phase stages of the cell cycle (Elia et al., 2003b). In addition, we
found that the Plk1 antibody precipitated equal amounts of Plx1
during the cell cycle (Fig. 7B), suggesting that Plx1 concentrations
remain stable in zygotes and therefore, per se, cannot account for the
cell cycle-speciﬁc IP3R1 MPM-2 phosphorylation. Together, these
results suggest that Plk1 binds and phosphorylates IP3R1 in vertebrate
oocytes/eggs in a cell cycle preferential manner.
Inactivation of the ERK pathway prevents IP3R1 cortical cluster
formation and MPM-2 IP3R1 phosphorylation at the MII stage
While our data collectively show that Plk1 is the IP3R1 MPM-2
generating kinase, the ﬁnding that abrogation of the ERK pathway
inhibits IP3R1MPM-2 phosphorylation after theMI stage suggests that
the ERK pathway has another novel regulatory role on IP3R1
phosphorylation. For this purpose, we examined whether its
Fig. 6. Overexpression of CA(T210D)-Plk1 accelerates GVBD and induces IP3R1 MPM-2 reactivity. (A) Percentage of oocytes (buffer-injected and injected with CA(T210D)-Plk1 mRNA)
that underwent GVBD after initiation of maturation; at least 20 oocytes were examined per group and time point. (B) Immunoblotting of lysates from uninjected GV oocytes, or from
GV oocytes injected with CA(T210D)-Plk1 mRNA or buffer (all in IBMX) and collected at 2 h. Immunoblottings were probed with MPM-2 (left panel) or p-Plk1 antibody (right panel)
and after stripping with IP3R1 (Rbt03) or Plk1 antibody, respectively. Quantiﬁcation of MPM-2 or p-Plk1/Plk1 intensity is shown in the graph below the immunoblotting panels.
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previous observations in starﬁsh oocytes (Okano-Uchida et al., 2003),
inactivation of the ERK pathway using U0126 did not affect Plk1
phosphorylation (data not shown). We therefore examined whether
inactivation of the ERK pathway might affect IP3R1 and Plk1
localization, and by doing so might compromise receptor phosphor-
ylation. We considered this possibility because research shows that
the ERK pathway is required for the egg's cortical reorganization
(Deng et al., 2005), for the migration of the meiotic spindle to the
oocyte cortex (Verlhac et al., 2000), and because several ERK
substrates contribute to maintain the conﬁguration of the MII spindle
(Terret et al., 2003; Lefebvre et al., 2002). Given that IP3R1 attains
prominent cortical cluster organization in MII eggs (Mehlmann et al.,
1996; Shiraishi et al., 1995) and that Plk1 accumulates to the spindle
poles in these cells (Wianny et al., 1998), it is possible that abrogation
of the ERK pathway during maturation might interfere with the
normal distribution of these molecules and therefore decrease their
functional association. Accordingly, oocyte maturation in the presence
of U0124 did not alter IP3R1 distribution, cortical cluster formation
(Figs. 8A, a; arrows; C; circles) or accumulation of Plk1 to the spindle
poles (Fig. 8A, b; arrowheads). Nevertheless, oocyte maturation in the
presence of U0126 diminished the numbers of IP3R1 clusters in the
ooplasm and prevented IP3R1 cortical cluster formation (Figs. 8B, a; D;
arrowheads); U0126 treatment also altered Plk1 localization, as
several additional Plk1 accumulations were seen around the spindle,
leading to a generally decreased IP3R1 and Plk1 overlap (Figs. 8B, b, cand panels displaying signal quantiﬁcation (Ad and Bd)). IP3R1 and
Plk1 signals were absent in negative control samples, which were
treated without primary antibodies but with both secondary
antibodies (E), or with the CT1 antibody pretreated with the
appropriate antigenic peptide (F). These results reveal that during
maturation the ERK pathway plays a novel regulatory role in the
localization of IP3R1 and Plk1, which is essential for IP3R1 MPM-2
phosphorylation in MII eggs.
Discussion
A consequence of the extensive biochemical and morphological
modiﬁcations that oocytes of vertebrate species undergo during
maturation is an enhancement of the egg’s [Ca2+]i releasing mechan-
isms required for fertilization. Here we show that one of these
modiﬁcations involves active MPM-2 epitope(s) phosphorylation of
IP3R1, and that Plk1 is the kinase responsible for this phosphorylation.
We found that IP3R1 and Plk1 associate in a cell cycle-preferential
manner, that they display diffuse distribution throughout the
ooplasm, and that they co-localize more prominently on areas around
the spindle/spindle poles. We demonstrate that while the ERK
pathway is dispensable for IP3R1 MPM-2 phosphorylation during
the early stages of maturation, it is required for this phosphorylation
at the MII stage. We also determined that the ERK pathway regulates
IP3R1 cellular distribution during the late stages of meiosis. Alto-
gether, our results in oocytes show that Plk1 and possibly other
Fig. 7. Plx1 is active and interacts maximally with IP3R1 in MII Xenopus egg extracts. (A)
Immunoblotting of MII and Interphase (Int) extracts of Xenopus eggs probed with Plk1
antibody. Arms of the bracket at the right of immunoblotting denote the upper and
lower location of Plx1 bands (B) IP of Plx1 (∼68 kDa) with IP3R1 (Rbt03; lanes 2 and 6)
or Plk1 antibody (lanes 3 and 7) in both MII (left) and Int (right) extracts; IP with non-
immune (Non-imm) serum (lanes 1 and 5) or beads alone (lanes 4 and 8) were used as
controls. Quantiﬁcation of Plx1 after IP is shown in the graph below the immunoblotting
panels.
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involved in its completion via regulation of the Ca2+ release channels
necessary for fertilization.
Plk1 is the MPM-2 epitope IP3R1 kinase
The precise nature of the molecular mechanisms underlying the
increased sensitivity of IP3R1s during oocyte maturation remains to be
elucidated. Nonetheless, IP3R1 phosphorylation is likely to play a
pivotal role in this process, as it has been associated with increased
Ca2+ release in numerous other cell systems (reviewed in Patterson et
al., 2004; Krizanova and Ondrias, 2003). In this study, we extend our
previous ﬁndings (Lee et al., 2006) by showing that the temporal
development of IP3R1 MPM-2 phosphorylation coincides with the
progressive increase in IP3R1 sensitivity that occurs during oocyte
maturation (Mehlmann and Kline,1994; Fujiwara et al., 1993). Because
a number of M-phase kinases are activated in close succession during
oocyte maturation, we used a combination of pharmacological and
molecular reagents to ascertain the kinase responsible for IP3R1MPM-
2 phosphorylation. Here we show that IP3R1 is a novel target for Plk1,
that it phosphorylates IP3R1 at an MPM-2 epitope, and that both
proteins interact in a cell-cycle preferential manner. The association of
Plk1 and IP3R1 is likely to be mediated by the PBD of Plk1, which binds
phosphorylated epitopes and reportedly targets Plk1 to its substrates
(Elia et al., 2003b). The preferred binding epitope of Plk1 is Ser–pSer/
pThr–Pro/X (Elia et al., 2003a), and a Ser–Ser–Pro motif is present in
IP3R1 (amino acids 1491–1493). This Ser–Ser–Pro site lies within a
larger consensus sequence remarkably reminiscent of the epitope
recognized by the MPM-2 antibody (Yaffe et al., 1997), raising the
prospect that Plk1 might phosphorylate this site. If this were so, it
would imply that Plk1 acts as its own priming kinase, which has been
shown to be the casewith other Plk1 substrates (Neef et al., 2003). Our
ﬁnding that injection of CA(T210D)-Plk1 mRNA induces IP3R1 MPM-2
reactivity in the absence of other M-phase kinases supports thispossibility. Nonetheless, in the absence of Cdk1 activity, such as it
occurs in OA-IBMX induced maturation, IP3R1 MPM-2 phosphoryla-
tion is noticeably lower than in control oocytes, suggesting that other
kinases assist Plk1-dependent phosphorylation of IP3R1.
Proteins displaying a PBD binding motif are likely to host Plk1
phosphorylation sites (Lowery et al., 2007). The consensus sequence
for Plk1 phosphorylation was ﬁrst described by Nakajima et al. (2003)
and consists of the following residues E/D-X-Ser/Thr-ψ-X-D/E, where
D/E stands for either of the acidic amino acids and ψ stands for a
hydrophobic amino acid; an expanded motif has recently been
described by Johnson et al. (2007). Examination of the IP3R1 sequence
reveals that it contains three highly conserved Plk1 phosphorylation
sites centered on residues Thr1048, Ser1890 and Thr2656. Moreover,
several minimal consensus sites for Plk1 (Lowery et al., 2007) are
scattered throughout the receptor sequence. It is therefore likely that
besides the MPM-2 epitope(s), Plk1 phosphorylates one or several of
these sites in oocytes and eggs. Nonetheless, further research will be
needed to ascertain how many sites are phosphorylated in vivo by
Plk1, and how this affects IP3R1 function. It is worth noting that while
Cdk1 or ERK does not phosphorylate the IP3R1MPM-2 epitope in eggs,
they could still act on IP3R1 by phosphorylating their own target sites
(Lee et al., 2006; Bai et al., 2006; Malathi et al., 2003). If this were the
case, it would underscore the importance of IP3R1 phosphorylation to
promote maximal Ca2+ release at fertilization to ensure completion
and exit of the meiotic program.
IP3R1 MPM-2 phosphorylation, Plk1 and IP3R1 cellular distribution and
the role of ERK
A second mechanism that might underlie the increased IP3R1
sensitivity in oocytes after maturation is the differential redistribution
of the receptor that culminates with the formation of conspicuous
cortical clusters (Stricker et al., 2006; reviewed in Kline, 2000). Here,
we show that the ERK pathway is required for IP3R1 cortical
redistribution, as eggs matured in the presence of the MEK inhibitor
U0126 were devoid of IP3R1 cortical clusters, although the receptor
dispersed from its spindle localization at MI. Inhibition of the ERK
pathway also reduced the overlap of Plk1 and IP3R1 signals on the
spindle poles, and this might explain, at least in part, the decreased
IP3R1 MPM-2 phosphorylation found in these eggs (present data and
Lee et al., 2006). Whether the reduced IP3R1 MPM-2 phosphorylation
is due to ERK's ability to impose priming phosphorylation(s) on IP3R1,
or is merely due to this pathway's regulatory role on cytoskeletal/
cortical re-organization (Deng et al., 2005; Verlhac et al., 1994)
remains to be elucidated. Likewise, whether the reported inability of
eggs maturated in the presence of U0126 to mount normal [Ca2+]i
oscillations (Matson and Ducibella, 2007; Lee et al., 2006) is due to
reduced IP3R1 phosphorylation or to the absence of cortical clusters or
to both remains to be determined. It is worth noting that these effects
of U0126 likely reﬂect speciﬁc suppression of the ERK pathway, as
duringmitosis I, which is naturally devoid of ERK activity, IP3R1s show
minor MPM-2 reactivity (this study and Lee et al., 2006), the ER does
not organize in cortical clusters (FitzHarris et al., 2003), and zygotes
display limited [Ca2+]i oscillatory ability (Jellerette et al., 2004).
Therefore, our results provide the framework for future studies to
discern the contribution of cortical clusters to IP3R1 sensitivity and
[Ca2+]i oscillatory capacity.
Plk1, Ca2+ release, cell cycle progression and cytokinesis
Plk1 plays essential roles in almost every phase of the cell cycle,
from promoting G2/M transition in oocytes, to making possible the
completion of meiosis after fertilization (Liu and Maller, 2005b; Rauh
et al., 2005), to being a critical regulator of mitosis and cytokinesis (Liu
and Maller, 2005a; reviewed in Barr et al., 2004). Remarkably, the
unfolding of several of these Plk1-regulated events is accompanied by
Fig. 8. The ERK pathway regulates IP3R1 redistribution and formation of IP3R1 cortical clusters during oocyte maturation. IF confocal images of IP3R1 (a; red; CT1 antibody), Plk1
(b; green), and merged images (c) in MII oocytes treated with U0124 (A, C) or U0126 (B, D). Asterisks and open arrowheads denote accumulations of IP3R1 and Plk1, respectively.
White arrows denote IP3R1 cortical clusters (Aa), and closed arrowheads denote their absence in U0126 matured eggs (D). Broken white lines in merged images denote the traces
used for intensity quantiﬁcation of IP3R1 and Plk1 signals (intensity panels on the right side of the ﬁgure; Ad, U0124, and Bd, U0126). Negative controls were stained without a
primary antibody but in the presence of both secondary antibodies (E; inset shows bright ﬁeld image), or with the CT1 antibody pre-incubated with antigenic peptide (F). Yellow
circles encircle representative IP3R1 clusters, which we deﬁned as having an area of ≥0.7 μm2 or a diameter of ≥1 μm. Ch in panel F denotes chromosomes (DNA staining with TO-PRO-
3 (blue)). Scale bar (Aa) indicates 10 μm.
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Nevertheless, whether Plk1 function and Ca2+ release are interdepen-
dent as well as themolecular underpinning of this association remains
unexplored. Here, we offer the ﬁrst demonstration that Plk1 associates
with and phosphorylates IP3R1 thereby providing a direct molecular
link between the cell cycle machinery and the Ca2+ release system. For
instance, it is well known that the function of Plx1, a Plk ortholog, is
required for MII exit in Xenopus eggs (Descombes and Nigg, 1998),
although earlier studies had shown that this event also requires Ca2+
release and activation of CaMKII (Lorca et al., 1993). The association
between these kinases, however, remained unclear until the recent
demonstration that CaMKII introduces a priming phosphorylation for
Plx1 on Emi2, the Anaphase Promoting Complex/Cyclosome (APC/C)
egg inhibitor (Madgwick et al., 2006; Tung et al., 2005). Following Plx1
phosphorylation, Emi2 is degraded, which is necessary for eggs to
escape the MII arrest (Liu and Maller, 2005b; Rauh et al., 2005). It is
therefore logical to envision a regulatory role for Plx1 on the Ca2+
channel responsible for the priming phosphorylation of a pivotal
substrate. Similarly, the distinct nuclear-associated IP3-mediated [Ca2+]
rises observed in syncytial Drosophila embryos (Parry et al., 2005)
might be under the regulation of Polo, given that in these embryos as
mitosis approaches both the ER (Parry et al., 2005) and Polo
(Moutinho-Santos et al., 1998) they gather on the spindle poles,
which we show are sites of IP3R1 and Plk1 co-localization. Lastly, the
demand for Ca2+ release during cytokinesis in Drosophila spermatoo-
cytes (Wong et al., 2005) and in Xenopus embryos (Muto and
Mikoshiba, 1998) might also be under a similar regulation, as boththe presence and function of Plk1/Polo and IP3R1 are required for
cleavage furrow formation and stability (Muto and Mikoshiba, 1998;
Mitsuyama and Sawai, 2001; Wong et al., 2005; Santamaria et al.,
2007) and, by this late stage of mitosis, most other M-phase kinases
have been inactivated (Neef et al., 2003).
In summary, our results reveal that IP3R1, a widespread Ca2+
channel responsible for the majority of [Ca2+]i release in non-muscle
cells, is a novel substrate for Plk1, a M-phase kinasewith a broad range
of functions during meiosis/mitosis and cytokinesis. We propose that
IP3R1 phosphorylation by Plk1, and possibly by other M-phase
kinases, is responsible for the delivery of spatially and temporally
regulated [Ca2+]i signals that ensure faithful progression and comple-
tion of meiosis/mitosis and cytokinesis.
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